GlassScriptPhysician profile
John S Schneider
NPI 1891951307
$74,138.54
in general payments reported to CMS, 2019-2025
15 companies · $75.21 in 2025
The $75.21 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73K · 2020: $14.15 · 2021: $309 · 2022: $143 · 2024: $155 · 2025: $75.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.38 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $69,201.40 | 2019 | |
| Medtronic USA, INC. | $2,317.47 | 2019 | |
| Olympus America INC. | $1,297.18 | 2019 | |
| Covidien LP | $428.19 | 2019 | |
| Intersect Ent, INC. | $197.61 | 2019 | |
| Medtronic, INC. | $190.78 | 2021 | |
| Karl Storz Endoscopy-America | $143.49 | 2021-2022 | |
| Genzyme Corporation | $127.93 | 2024 | |
| Integra Lifesciences Corporation | $68.45 | 2024-2025 | Cusa Clarity, Codman Certas, Codman Hakim |
| Abbott Laboratories | $51.31 | 2022 | |
| Amgen INC. | $34.00 | 2025 | |
| Abbvie INC. | $28.28 | 2022 | |
| Smith+Nephew, INC. | $26.30 | 2020-2021 | |
| Stryker Corporation | $19.63 | 2021 | |
| Ambu INC. | $6.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.